1,174 results on '"Pavletic, Steven Z."'
Search Results
2. Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease
3. High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention
4. Identification of Fibroinflammatory and Fibrotic Transcriptomic Subsets of Human Cutaneous Sclerotic Chronic Graft-Versus-Host Disease
5. Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions
6. Chronic gvhd dictionary—eurograft cost action initiative consensus report
7. Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNA
8. Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes
9. Motor ability, function, and health-related quality of life as correlates of symptom burden in patients with sclerotic chronic graft-versus-host disease receiving imatinib mesylate.
10. Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
11. Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials
12. High-dose Alemtuzumab-Cyclosporine vs Tacrolimus-Methotrexate-Sirolimus for Chronic Graft-versus-Host Disease Prevention
13. Collection of peripheral blood mononucleated cells for chronic graft-versus-host disease immunology research: safety and effectiveness of leukapheresis in 132 patients
14. Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Transplantation and Cellular Therapy
15. Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force
16. The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease
17. Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease
18. Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD
19. Impaired Bone Mineral Density in Pediatric Patients with Chronic Graft-versus-Host Disease
20. Development and psychometric testing of a pediatric chronic graft-versus-host disease symptom scale: protocol for a two-phase, mixed methods study
21. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report
22. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report
23. Heightened TLR7 Primes BCR-Activated Cells in Chronic Graft-Versus-Host Disease for Effector Functions
24. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report
25. Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study
26. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report
27. Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease
28. A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease
29. Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI
30. Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation
31. Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease—results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health
32. Study protocol: Close Assessment and Testing for Chronic Graft-vs.-Host disease (CATCH).
33. Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia
34. W“H-Y” antigen/HLA complexes in chronic GVHD
35. Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy
36. Characterization of Hepatic Dysfunction in Subjects Diagnosed With Chronic GVHD by NIH Consensus Criteria
37. Correlation of Patient-Reported Outcomes with Clinical Organ Responses: Data from the Belumosudil Chronic Graft-versus-Host Disease Studies
38. Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis
39. Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD
40. Red cell distribution width as a new prognostic biomarker in refractory chronic graft-versus-host disease
41. Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD
42. Hematopoietic Stem Cell Transplantation
43. Contributors
44. Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis
45. Impaired Bone Mineral Density in Pediatric Patients with Chronic Graft-versus-Host Disease
46. Introduction to a review series on emerging immunotherapies for hematologic diseases
47. Correction: Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study
48. Challenges in Conducting Studies in Chronic Graft-versus-Host Disease
49. Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients
50. EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.